Skip to Content

W1 (Pyridostigmine Bromide Extended-Release 180 mg)

Pill with imprint W1 is Yellow, Capsule-shape and has been identified as Pyridostigmine Bromide Extended-Release 180 mg. It is supplied by Global Pharmaceuticals, Division of Impax Laboratories Inc..

Pyridostigmine is used in the treatment of myasthenia gravis; dysautonomia; nerve agent pretreatment; reversal of nondepolarizing muscle relaxants and belongs to the drug class cholinergic muscle stimulants. Risk cannot be ruled out during pregnancy. Pyridostigmine 180 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for W1

Pyridostigmine Bromide Extended-Release

Imprint:
W1
Strength:
180 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Cholinergic muscle stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Global Pharmaceuticals, Division of Impax Laboratories Inc.
National Drug Code (NDC):
00115-1404

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide